GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » CERo Therapeutics Holdings Inc (NAS:CERO) » Definitions » Change In Prepaid Assets

CERO (CERo Therapeutics Holdings) Change In Prepaid Assets : $0.03 Mil (TTM As of Sep. 2024)


View and export this data going back to 2024. Start your Free Trial

What is CERo Therapeutics Holdings Change In Prepaid Assets?

CERo Therapeutics Holdings's Change In Prepaid Assets for the quarter that ended in Sep. 2024 was $0.00 Mil. It means CERo Therapeutics Holdings's Prepaid Assets stayed the same from Jun. 2024 to Sep. 2024 .

CERo Therapeutics Holdings's Change In Prepaid Assets for the fiscal year that ended in Dec. 2022 was $0.05 Mil. It means CERo Therapeutics Holdings's Prepaid Assets increased by $0.05 Mil from Dec. 2021 to Dec. 2022 .


CERo Therapeutics Holdings Change In Prepaid Assets Historical Data

The historical data trend for CERo Therapeutics Holdings's Change In Prepaid Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CERo Therapeutics Holdings Change In Prepaid Assets Chart

CERo Therapeutics Holdings Annual Data
Trend Dec21 Dec22
Change In Prepaid Assets
0.10 0.05

CERo Therapeutics Holdings Quarterly Data
Dec21 Mar22 Dec22 Mar23 Jun23 Sep23 Mar24 Jun24 Sep24
Change In Prepaid Assets Get a 7-Day Free Trial Premium Member Only -0.08 0.03 - - -

CERo Therapeutics Holdings Change In Prepaid Assets Calculation

Change In Prepaid Assets is any increase or decrease between periods of the prepaid assets.

Change In Prepaid Assets for the trailing twelve months (TTM) ended in Sep. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.03 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


CERo Therapeutics Holdings Change In Prepaid Assets Related Terms

Thank you for viewing the detailed overview of CERo Therapeutics Holdings's Change In Prepaid Assets provided by GuruFocus.com. Please click on the following links to see related term pages.


CERo Therapeutics Holdings Business Description

Comparable Companies
Traded in Other Exchanges
N/A
Address
201 Haskings Way, Suite 230, South San Francisco, San Francisco, CA, USA, 94080
CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.